Quidel Receives Preliminary Contract Leading To Definitive Agreement For $71M Under NIH's RADx-ATP Program To Accelerate Expansion Of It's Manufacturing Capacity For Sofia Coronavirus Antigen Detection Test For Rapid Diagnosis